Neuronoff, Inc.
PrivateLast Round
Seed
Oct 8, 2025
Total Funding Raised
$12.23M
Company Overview
Neuronoff, Inc. is a medical devices company developing an injectable electrode platform for minimally invasive neuromodulation to treat chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Sensors, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuronoff, Inc. Comps
Public and private peers based on sector, stage, and business model.
Neuronoff, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 8, 2025 | ||||
| Grant | Jan 30, 2025 | ||||
| Grant | Aug 1, 2023 | ||||
| Grant | Oct 31, 2019 |
Neuronoff, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| U.S. Department of Defense | Grant |
| NIH RADx | Grant |
| MedTech Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Announced successful chronic large animal demonstration of IPG-compatible Injectrode platform.
Neuronoff, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuronoff, Inc.'s valuation, stock price, and market status.